Evidence mapPaperPMID 41495145Full record

ArticleScientific reports2026

Association between atherogenic index of plasma and hypertension in children and adolescents based on LightGBM prediction model.

Jialiang Zhu, Ruiheng Zhang, Chen Zhang, Yali Yan, Yajing Guo, Gang Tian, Jinming Wang, Min Liu, Yibin Hao

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jialiang Zhu *Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
Ruiheng Zhang *College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
Chen Zhang *Department of Hypertension, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
Yali YanHenan Provincial Center for Disease Control and Prevention, Zhengzhou, China.
Yajing GuoCollege of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
Gang TianHenan Province Hypertension Precision Prevention and Control Engineering Research Center, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
Jinming WangMedical Genetics Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, People's Republic of China.
Min LiuDepartment of Hypertension, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China. liumin136@126.com.
Yibin HaoHenan Province Hypertension Precision Prevention and Control Engineering Research Center, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China. haoyibin0708@163.com.

Funding

Construction and Application of an Intelligent Prevention and Treatment System for Hypertension in Children and Adolescents in the Central Plains Region HNCRD202402Creation and Application of an Intelligent "Four Highs" Early Warning and Prevention Model 251111312800Multi-omics Pathogenesis and Prospective Intervention Cohort Study on Hypertension in Children and Adolescents in Henan Province 231111313400Research and Application of Large Model-Driven Hypertension Pathogenesis, Screening Models, and Intervention Paradigms SBGJ202401001
6 · The paper itself

Abstract

The prevalence of hypertension in children and adolescents is on the rise, highlighting the need to identify effective biomarkers for risk assessment. The Atherogenic Index of Plasma (AIP), which reflects dyslipidemia, has demonstrated predictive value in adult cardiovascular diseases. However, its association with hypertension in children and adolescents remains unclear. A total of 28,844 children and adolescents from 18 prefecture-level cities in Henan Province, China, were enrolled between 2023 and 2024. After screening, 27991 participants were included in the final analysis. Blood pressure was measured on three non-consecutive days. AIP was calculated as log₁₀ (triglycerides / high-density lipoprotein cholesterol). Multivariate logistic regression, restricted cubic splines, and mediation effect analysis were employed to explore the association between AIP and hypertension. 11 types of machine learning models were constructed to evaluate the predictive value of AIP: first, the dataset was split into a training set and a testing set; variable selection was performed using the Boruta algorithm only within the training set to avoid information leakage from the testing set, and SHAP (SHapley Additive exPlanations) analysis was further conducted to interpret the role of each variable. The AIP level in the hypertensive group was significantly higher than that in the non-hypertensive group (P<0.001). After adjustment by multiple models, participants in the 4th quartile (Q4) of AIP had a 20% higher risk of hypertension compared with those in the 1st quartile (Q1) (OR=1.20, P=0.027). The association was stronger in males (Q4 HR=2.38) than in females (Q4 HR=1.76), and there was a non-linear association between AIP and hypertension (P for non-linearity=0.007). Waist-to-height ratio (WHtR) (mediation proportion: 51.7%) and uric acid (UA) (mediation proportion: 20.7%) were identified as key mediators. The LightGBM model exhibited the relatively optimal predictive performance (AUC=0.7376), and SHAP analysis confirmed that AIP had an independent predictive value for hypertension. Elevated AIP is significantly associated with an increased risk of hypertension in children and adolescents, with gender differences and non-linear characteristics observed. AIP may serve as a potential biomarker for hypertension risk assessment in this population.

Indexed as

AtherosclerosisHypertensionAdolescentBiomarkersBlood PressureBoosting Machine Learning AlgorithmsChildChinaCholesterol, HDLFemaleHumansMachine LearningMaleRisk AssessmentRisk FactorsTriglyceridesBiomarkersCholesterol, HDLTriglyceridesAtherogenic index of plasma (AIP)Children and adolescentsHypertensionMachine learningMediation effect

Identifiers

PMID41495145
PMCPMC12855911

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.